Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · IEX Real-Time Price · USD
26.56
+0.02 (0.08%)
At close: Jul 19, 2024, 4:00 PM
26.45
-0.11 (-0.41%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Dianthus Therapeutics Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for DNTH stock have an average target of 42.4, with a low estimate of 38 and a high estimate of 51. The average target predicts an increase of 59.64% from the current stock price of 26.56.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 16, 2024.
Analyst Ratings
The average analyst rating for DNTH stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 3 | 3 | 3 |
| Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 5 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Jun 27, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $40 | Strong Buy | Initiates | $40 | +50.60% | May 16, 2024 |
| Wedbush | Wedbush | Buy Maintains $33 → $38 | Buy | Maintains | $33 → $38 | +43.07% | May 10, 2024 |
| Raymond James | Raymond James | Buy Maintains $34 → $51 | Buy | Maintains | $34 → $51 | +92.02% | Apr 18, 2024 |
| Jefferies | Jefferies | Strong Buy Maintains $22 → $39 | Strong Buy | Maintains | $22 → $39 | +46.84% | Mar 22, 2024 |
Financial Forecast
Revenue This Year
1.82M
from 2.83M
Decreased by -35.67%
Revenue Next Year
1.36M
from 1.82M
Decreased by -25.08%
EPS This Year
-2.24
from -8.45
EPS Next Year
-2.65
from -2.24
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 3.8M | 4.2M | 4.6M |
| Avg | 1.8M | 1.4M | 1.7M |
| Low | 856,520 | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 35.6% | 131.8% | 240.4% |
| Avg | -35.7% | -25.1% | 23.5% |
| Low | -69.7% | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.73 | -2.08 | -2.22 |
| Avg | -2.24 | -2.65 | -3.32 |
| Low | -3.22 | -3.23 | -5.24 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.